Annual ROE
-35.21%
-8.08%-29.78%
December 31, 2023
Summary
- As of February 6, 2025, TRVI annual return on equity is -35.21%, with the most recent change of -8.08% (-29.78%) on December 31, 2023.
- During the last 3 years, TRVI annual ROE has risen by +84.86% (+70.68%).
- TRVI annual ROE is now -29.78% below its all-time high of -27.13%, reached on December 31, 2022.
Performance
TRVI ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-63.30%
-13.38%-26.80%
September 30, 2024
Summary
- As of February 6, 2025, TRVI quarterly return on equity is -63.30%, with the most recent change of -13.38% (-26.80%) on September 30, 2024.
- Over the past year, TRVI quarterly ROE has dropped by -31.79% (-100.89%).
- TRVI quarterly ROE is now -139.95% below its all-time high of -26.38%, reached on June 30, 2023.
Performance
TRVI Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
TRVI ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.8% | -100.9% |
| 3 y3 years | +70.7% | +63.7% |
| 5 y5 years | +89.3% | +8.6% |
TRVI ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -29.8% | +82.3% | -139.9% | +72.8% |
| 5 y | 5-year | -29.8% | +82.3% | -139.9% | +72.8% |
| alltime | all time | -29.8% | +89.3% | -139.9% | +80.8% |
Trevi Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -63.30%(+26.8%) |
| Jun 2024 | - | -49.92%(+26.3%) |
| Mar 2024 | - | -39.54%(+25.5%) |
| Dec 2023 | -35.21%(+29.8%) | -31.51%(+16.0%) |
| Sep 2023 | - | -27.17%(+3.0%) |
| Jun 2023 | - | -26.38%(-11.3%) |
| Mar 2023 | - | -29.74%(-26.5%) |
| Dec 2022 | -27.13%(-86.4%) | -40.44%(-37.8%) |
| Sep 2022 | - | -65.00%(-48.1%) |
| Jun 2022 | - | -125.33%(-46.0%) |
| Mar 2022 | - | -232.27%(+19.5%) |
| Dec 2021 | -198.77% | -194.29%(+11.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | -174.53%(+29.8%) |
| Jun 2021 | - | -134.45%(+30.3%) |
| Mar 2021 | - | -103.16%(+17.9%) |
| Dec 2020 | -120.07%(+151.4%) | -87.51%(+30.1%) |
| Sep 2020 | - | -67.28%(+14.2%) |
| Jun 2020 | - | -58.90%(+13.8%) |
| Mar 2020 | - | -51.74%(-2.9%) |
| Dec 2019 | -47.76%(-85.5%) | -53.26%(-23.1%) |
| Sep 2019 | - | -69.22%(-16.0%) |
| Jun 2019 | - | -82.37%(-63.4%) |
| Mar 2019 | - | -225.08%(-31.6%) |
| Dec 2018 | -328.83%(+277.9%) | -328.83% |
| Dec 2017 | -87.02% | - |
FAQ
- What is Trevi Therapeutics annual return on equity?
- What is the all time high annual ROE for Trevi Therapeutics?
- What is Trevi Therapeutics annual ROE year-on-year change?
- What is Trevi Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Trevi Therapeutics?
- What is Trevi Therapeutics quarterly ROE year-on-year change?
What is Trevi Therapeutics annual return on equity?
The current annual ROE of TRVI is -35.21%
What is the all time high annual ROE for Trevi Therapeutics?
Trevi Therapeutics all-time high annual return on equity is -27.13%
What is Trevi Therapeutics annual ROE year-on-year change?
Over the past year, TRVI annual return on equity has changed by -8.08% (-29.78%)
What is Trevi Therapeutics quarterly return on equity?
The current quarterly ROE of TRVI is -63.30%
What is the all time high quarterly ROE for Trevi Therapeutics?
Trevi Therapeutics all-time high quarterly return on equity is -26.38%
What is Trevi Therapeutics quarterly ROE year-on-year change?
Over the past year, TRVI quarterly return on equity has changed by -31.79% (-100.89%)